| Literature DB >> 29287995 |
Yehudi Bloch1, Laura Bouchareychas2, Romain Merceron1, Katarzyna Składanowska1, Lien Van den Bossche3, Sammy Detry1, Srinath Govindarajan4, Dirk Elewaut4, Filomeen Haerynck5, Melissa Dullaers6, Iannis E Adamopoulos2, Savvas N Savvides7.
Abstract
Interleukin-23 (IL-23), an IL-12 family cytokine, plays pivotal roles in pro-inflammatory T helper 17 cell responses linked to autoimmune and inflammatory diseases. Despite intense therapeutic targeting, structural and mechanistic insights into receptor complexes mediated by IL-23, and by IL-12 family members in general, have remained elusive. We determined a crystal structure of human IL-23 in complex with its cognate receptor, IL-23R, and revealed that IL-23R bound to IL-23 exclusively via its N-terminal immunoglobulin domain. The structural and functional hotspot of this interaction partially restructured the helical IL-23p19 subunit of IL-23 and restrained its IL-12p40 subunit to cooperatively bind the shared receptor IL-12Rβ1 with high affinity. Together with structural insights from the interaction of IL-23 with the inhibitory antibody briakinumab and by leveraging additional IL-23:antibody complexes, we propose a mechanistic paradigm for IL-23 and IL-12 whereby cognate receptor binding to the helical cytokine subunits primes recruitment of the shared receptors via the IL-12p40 subunit.Entities:
Keywords: Crohn’s disease; IL-12Rβ1; IL-23; IL-23 receptor; cytokine-receptor complex; inflammation; inflammatory bowel disease; psoriasis; rheumatoid arthritis; structure
Mesh:
Substances:
Year: 2017 PMID: 29287995 PMCID: PMC5773378 DOI: 10.1016/j.immuni.2017.12.008
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745